4//SEC Filing
LAPOINTE ANTHONY GREGG 4
Accession 0000905148-25-001933
CIK 0001034842other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 5:27 PM ET
Size
7.1 KB
Accession
0000905148-25-001933
Insider Transaction Report
Form 4
Lapointe Gregg Anthony
Director
Transactions
- Award
Common Stock
2025-05-23+2,500→ 12,500 total - Award
Stock Option (Right to Buy)
2025-05-23+3,000→ 3,000 totalExercise: $18.95Exp: 2035-05-23→ Common Stock (3,000 underlying)
Footnotes (3)
- [F1]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.
- [F2]This number has been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
- [F3]The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001331860
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 5:27 PM ET
- Size
- 7.1 KB